Ravantage 45
Ravantage 45 (ractopamine hydrochloride Type A medicated article)
Approved
Approval ID
2c1155f4-dd52-4627-acff-ab195deca9d9
Product Type
OTC TYPE A MEDICATED ARTICLE ANIMAL DRUG LABEL
Effective Date
Apr 1, 2025
Manufacturers
FDA
Huvepharma, Inc
DUNS: 619153559
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
ractopamine hydrochloride
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code23243-5278
Application NumberANADA200768
Product Classification
M
Marketing Category
C73583
G
Generic Name
ractopamine hydrochloride
Product Specifications
Route of AdministrationORAL
Effective DateApril 1, 2025
FDA Product Classification
INGREDIENTS (4)
CASTOR OILInactive
Code: D5340Y2I9G
Classification: IACT
povidoneInactive
Code: FZ989GH94E
Classification: IACT
CORN COBInactive
Code: XXP8V4H4NY
Classification: IACT
ractopamine hydrochlorideActive
Quantity: 45.4 g in 0.45 kg
Code: 309G9J93TP
Classification: ACTIB